advisorsecurities master

SCNIScinai Immunotherapeutics Ltd. American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
21407
Ticker
SCNI
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2015-05-12
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
SCNI

Detail

Enriched 2026-08-14 20:47

Market cap
$1,276,837.6
Shares outstanding (class)
5,169,383
Shares outstanding (weighted)
5,169,383
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
45
Location
JERUSALEM, L3
Description

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data